feed,title,long_url,short_url
MarketWatch,Xeris Biopharma soars on premarket leading volume after FDA approval of Cushing's syndrome treatment,http://www.marketwatch.com/news/story/xeris-biopharma-soars-premarket-leading/story.aspx?guid=%7B69DD7220%2D5A8E%2D4315%2D9336%2DD2D779B38087%7D&siteid=rss,https://on.mktw.net/3mMkaii
